Extensions

Patent US10482517, titled "Providing a simulation of wearing items such as garments and/or accessories," has the following characteristics as of April 26, 2026:

Patent Term Adjustments (PTA) and Extensions (PTE):

• Patent Term Adjustments (PTA): PTA is granted to compensate for certain delays caused by the USPTO during the patent examination process for utility or plant applications filed on or after May 29, 2000. These delays include, but are not limited to: issuing an office action or notice of allowance more than 14 months after filing, acting more than four months after an applicant's reply, or issuing a patent more than four months after payment of the issue fee. It also includes delays if the application is pending for more than three years, excluding applicant-caused delays. The specific PTA granted for US10482517 would typically be indicated on the patent itself or in the Issue Notification Letter. Without access to the official USPTO record for this specific patent's issuance details, the exact PTA amount cannot be determined.
• Patent Term Extensions (PTE): PTE is available under the Hatch-Waxman Act for patents claiming products (such as human and veterinary pharmaceuticals, food additives, color additives, and medical devices) that require regulatory approval prior to being sold. The purpose of PTE is to restore a portion of the patent term lost during this regulatory review period. To qualify, an application for PTE must be filed within 60 days of the product's marketing approval. There is no indication from the provided information that US10482517, which relates to virtual try-on technology, would be eligible for a Patent Term Extension under these provisions.

Continuation and Divisional Applications:

• US Patent 10482517 is explicitly stated to be a continuation of U.S. patent application Ser. No. 13/592,159, filed August 22, 2012 (now U.S. Patent No. 9,183,581), which in turn is a continuation of U.S. patent application Ser. No. 12/822,168, filed June 23, 2010 (now U.S. Pat. No. 8,275,590). This demonstrates a chain of continuation applications.
• The original application (Ser. No. 12/822,168) claims priority benefit to U.S. Provisional Patent Application Ser. No. 61/233,364 and U.S. Provisional Patent Application Ser. No. 61/233,377, both filed August 12, 2009.
• Divisional Applications: A divisional application is filed when the USPTO requires restriction of claims to one invention when two or more independent and distinct inventions are claimed in one application. The provided text explicitly mentions the patent as a continuation, but there is no specific mention of divisional applications directly tied to US10482517 within the provided information.

Related Family Members:
Based on the continuation chain provided, the following are related family members:

• U.S. Patent No. 9,183,581 (from application Ser. No. 13/592,159).
• U.S. Pat. No. 8,275,590 (from application Ser. No. 12/822,168).
• U.S. Provisional Patent Application Ser. No. 61/233,364 (priority document).
• U.S. Provisional Patent Application Ser. No. 61/233,377 (priority document).
• US20160063592A1 (other version/publication of the same family).

Projected Expiration Date:
The stated adjusted expiration date for US10482517 is July 9, 2031. This date already accounts for any patent term adjustments (PTA). Patent term extensions (PTE) are generally for specific types of products requiring regulatory approval (e.g., pharmaceuticals), and this patent does not appear to fall into that category.